Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Appendix 3B

19 Nov 2012 07:00

RNS Number : 3964R
Oilex Limited
19 November 2012
 



 

 

 

 

 

 

19 November 2012

 

 

 

Dear Sirs

 

Appendix 3B

 

We enclose an Appendix 3B detailing the following changes to unlisted options:

 

16,687,500 unlisted options exercisable at $0.30 each on 10 November 2012 lapsed unexercised.

 

 

For and on behalf of Oilex Ltd

 

 

 

 

 

David Peterson

Company Secretary

 

 

cc: Directors - BM/SB/RM

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

 

 

Appendix 3B

 

New issue announcement,application for quotation of additional securitiesand agreement

 

 

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

 

Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003, 24/10/2005, 01/08/2012.

 

 

Name of entity

 OILEX LTD

 

ABN

50 078 652 632

 

We (the entity) give ASX the following information.

 

 

Part 1 ‑ All issues

You must complete the relevant sections (attach sheets if there is not enough space).

 

1.

+Class of +securities issued or to be issued

 

2.

Number of +securities issued or to be issued (if known) or maximum number which may be issued

 

3.

Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)

 

 

 

 

4.

Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities?

 

If the additional securities do not rank equally, please state:

·; the date from which they do

·; the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

·; the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

 

 

 

 

 

 

 

5.

Issue price or consideration

 

 

 

 

6.

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

 

 

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

 

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

 

 

6b

The date the security holder resolution under rule 7.1A was passed

 

 

6c

Number of +securities issued without security holder approval under rule 7.1

 

 

6d

Number of +securities issued with security holder approval under rule 7.1A

 

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

 

 

6f

Number of securities issued under an exception in rule 7.2

 

6g

If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation.

 

6h

If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements

 

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

 

7.

Dates of entering +securities into uncertificated holdings or despatch of certificates

 

 

 

 

 

 

Number

+Class

8.

Number and +class of all +securities quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

 

354,676,843

 

151,994,967

 

Ordinary Shares

 

Options exercisable at 15 cents expiring 7 September 2015

 

 

 

 

 

 

 

 

 

 

 

Number

+Class

9.

Number and +class of all +securities not quoted on ASX (including the securities in clause 2 if applicable)

 

 

 

75,000

4,150,000

8,737,500

75,000

 

 

 

$0.50 Options due 01/08/2013

$0.30 Options due 01/07/2014

$0.37 Options due 10/11/2014

$0.63 Options due 01/08/2015

 

 

10.

Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests)

 

 

 

 

 Part 2 ‑ Bonus issue or pro rata issue [Item 11 to 33 - Not Applicable]

 

 

 

Part 3 ‑ Quotation of securities

You need only complete this section if you are applying for quotation of securities

 

34

Type of securities

(tick one)

(a)

X

Securities described in Part 1

(b)

All other securities

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

 

 

 

 

 

 

 

 

 

 

 

 

Entities that have ticked box 34(a) [Items 35 to 42 - Not Applicable]

Additional securities forming a new class of securities

 

 

 

 

Quotation agreement

 

1. +Quotation of our additional +securities is in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.

 

2. We warrant the following to ASX.

 

·; The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.

·; There is no reason why those +securities should not be granted +quotation.

·; An offer of the +securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

 

·; Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

·; We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the +securities to be quoted, it has been provided at the time that we request that the +securities be quoted.

·; If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.

 

3. We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

 

4. We give ASX the information and documents required by this form. If any information or document not available now, will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

 

 

Sign here: .............................................. Date: 19 November 2012

 

(Company Secretary)

 

 

Print name: David Peterson

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISLIFEILALALIF
Date   Source Headline
11th Nov 20139:22 amRNSResults of Annual General Meeting 11 November 2013
11th Nov 20137:15 amRNSOILEX AGM Presentation November 2013
11th Nov 20137:11 amRNSOILEX AGM Chairman's Review
6th Nov 20137:00 amRNSAppendix 3Y
6th Nov 20137:00 amRNSAppendix 3B
30th Oct 20137:00 amRNSQuarterly Report to Shareholders 30 September 2013
28th Oct 20137:00 amRNSCambay Drilling Update
28th Oct 20137:00 amRNSResults of General Meeting - 28 October 2013
23rd Oct 20138:59 amRNSOilex accepts offer of two Canning Basin Permits
14th Oct 20137:00 amRNSOilex awarded 2 Exploration Permits, Canning Basin
10th Oct 20137:00 amRNSNotice of Annual General Meeting 11 November 2013
10th Oct 20137:00 amRNSOilex Ltd 2013 Annual Report to Shareholders
7th Oct 20139:31 amRNSChief Operating Officer
4th Oct 20137:00 amRNSResult of General Meeting - 4 October 2013
3rd Oct 201310:05 amRNSMagna Cambay Transaction Update
3rd Oct 20137:50 amRNSCanning Basin SPA-0055 Update
27th Sep 20137:00 amRNSNotice of General Meeting - 28 October 2013
25th Sep 20137:00 amRNSInterview with Oilex Ltd Managing Director
12th Sep 20137:20 amRNSWaiver of ASX Listing Rule 7.3.2
11th Sep 201310:23 amRNSFinancial Report for Year Ended 30 June 2013
6th Sep 20137:00 amRNSAppendix 3B
3rd Sep 20137:00 amRNSNotice of General Meeting - 4 October 2013
30th Aug 20137:00 amRNSPlacement to Raise $3.4 Million
28th Aug 20138:28 amRNSTrading Halt
27th Aug 201311:47 amRNSOilex Investor Presentation
20th Aug 20137:58 amRNSUK Broker Update
19th Aug 201312:50 pmRNSBhandut-3 Isochronal Production Test Report
9th Aug 201312:40 pmRNSCambay PSC - Equity Sale Agreeement
2nd Aug 20137:00 amRNSAppendix 3B
31st Jul 20139:19 amRNSQuarterly Report to Shareholders 30 June 2013
25th Jul 20137:00 amRNSCanning Basin SPA-0055 Update
12th Jul 201310:00 amRNSJPDA 06-103 PSC Update
1st Jul 20137:21 amRNSAppendix 3B
17th May 20137:00 amRNSAppendix 3B
3rd May 20137:00 amRNSInterview with Oilex Ltd Managing Director
29th Apr 20137:00 amRNSQuarterly Report to Shareholders
22nd Apr 20137:00 amRNSOILEX Investor Presentation April 2013
19th Apr 20137:00 amRNSCanning Basin Special Prospecting Authority Award
11th Apr 20138:25 amRNSAppendix 3B
11th Apr 20137:43 amRNSCambay - Gas Sales Agreeement signed
10th Apr 20137:00 amRNSCambay Work Programme & Budget Approved
4th Apr 20139:35 amRNSAppendix 3B
8th Mar 20137:39 amRNSAppendix 3B
25th Feb 20137:51 amRNSAppendix 3B
25th Feb 20137:00 amRNSAppendix 3Y
21st Feb 20138:05 amRNSAppendix 3B
15th Feb 20139:11 amRNSInterim Financial Report 31 December 2012
30th Jan 20137:00 amRNSResignation and Appointment of Company Secretary
29th Jan 201310:36 amRNSQuarterly Report to Shareholders 31 December 2012
25th Jan 20137:00 amRNSJPDA06-103 PRODUCTION SHARING CONTRACT - EXTENSION

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.